Our digital wizards have created another great video, this one about the more than 900 new target="_blank">biologic medicines that are currently in development to treat more than 100 diseases. It features both researchers - including the chief medical officer of Novo Nordisk, Dr.
Most Recent Posts
The Wall Street Journal's Laura Landro wrote today about how patients can benefit from programs that encourage improved adherence to needed medicines.
Every day at PhRMA, we work to support our member companies, whose employees are dedicated to bringing new medicines to the patients who need them.
Lisa Tharp of the Ohio State Grange has written an interesting piece printed in the Columbus (OH) Dispatch: Medicare Part D plan works just fine as it is. A key insight: "...competition has driven down costs dramatically. Work from the Medicare trustees shows that the national average monthly premium for a Part D plan this year is just $30, well under the $53 projected at the program's creation.
Ah, flu season will soon be upon us. I see my supermarket and local pharmacy signing people up for this year's flu shot. Here's a piece from one of my favorite nerd sites talking about this years' vaccine and why it is important to be vaccinated.
Last week, my colleague Grady Forrer wrote about non-communicable diseases, which are posing new and growing threats to the developing world, including countries like India.
Recently, we had the chance to speak with Mary Grealy, president of the Healthcare Leadership Council (HLC), about the Medicare prescription drug benefit. Grealy is also the co-chair of Medicare Today, a program intended to help seniors understand and enroll in Medicare Part D.